Sort
30,917 grants matching “tumor microenvironment”
The Regulatory Control Mechanisms of Cross-presentation by Toll-like Receptors
$423,750Julie Magarian Blander · Icahn School Of Medicine At Mount Sinai · R01 · FY2008 · AI
Mechanosensing Via Cytoskeletal Strain
$423,750Gregory M Alushin · Rockefeller University · DP5 · FY2018 · OD
The Regulatory Control Mechanisms of Cross-presentation by Toll-like Receptors
$423,750Julie Magarian Blander · Icahn School Of Medicine At Mount Sinai · R56 · FY2007 · AI
IRON CHELATION THERAPY FOR OVARIAN CANCER: REPROGRAMMING THE TUMOR MICROENVIRONMENT AND THE HOST MICROBIOME TO CONTROL DISEASE PROGRESSION
$423,750Weill Medical College Of Cornell University · · FY2020 · Defense Health Agency
Directing the metabolic fate of CAR T cells
$423,662Carl H. June · University Of Pennsylvania · R01 · FY2022 · CA
Genomics and Computational Biology Shared Resource
$423,648Kelly A Frazer · University Of California, San Diego · P30 · FY2024 · CA
Bioinformatics Technology to Characterize Tumor Infiltrating Immune Repertoires
$423,633Heng Li · Dana-Farber Cancer Inst · U01 · FY2020 · CA
Microenvironmental Influences in Cancer
$423,619Lynn M Matrisian · Vanderbilt University · T32 · FY2010 · CA
Integrative Computational Models for Decoding Disease Mechanisms and Predicting Drug Synergies in Spatial Transcriptomics
$423,616Ying Ma · Brown University · R35 · FY2025 · GM
Antagonistic role of ARF and ADAR1 in triple-negative breast cancer
$423,560Jason Weber · Washington University · R01 · FY2022 · CA
Autophagy as a microenvironmental regulator of tumorigenesis and resistance
$423,504Jayanta Debnath · University Of California, San Francisco · R01 · FY2014 · CA
Targeting the Bone Marrow Microenvironment In Acute Lymphocytic Leukemia
$423,502Geoffrey L Uy · Washington University · P50 · FY2017 · CA
Dissecting the immunological mechanisms associated with prostate cancer progression in African-American men and exploring epigenetics-based immune modulation for therapy
$423,486Dennis O Adeegbe · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2021 · CA
Preventing Melanoma Metastasis by Targeting Lipid Vulnerabilities in Lymph
$423,468Jessalyn Ubellacker · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2024 · CA
Proj 4: Triggers for the Induction of T Cell Dysfunction on T cells in Glioblastoma
$423,426Vijay K Kuchroo · Brigham And Women'S Hospital · P01 · FY2024 · CA
Racial differences in Immunogenetic Tumorigenesis of Head and Neck Squamous Cell Carcinoma
$423,409David Sidransky · Johns Hopkins University · R01 · FY2025 · CA
IGF::OT::IGF ANTI FUSOBACTERIUM NUCLEATUM VACCINE FOR COLORECTAL CANCER IMMUNOPREVENTION
$423,381Steven Monroe Lipkin · Weill Medical Coll Of Cornell Univ · N01 · FY2016 · CA
Mechanisms of immunotherapy response and resistance in pancreatic ductal adenocarcinoma
$423,354Ingunn Margarete Stromnes · University Of Minnesota · R01 · FY2022 · CA
Mechanisms of immunotherapy response and resistance in pancreatic ductal adenocarcinoma
$423,354Ingunn Margarete Stromnes · University Of Minnesota · R01 · FY2023 · CA
Project 3: Adaptive immunity to MCPyV in Merkel cell carcinoma
$423,325David M Koelle · University Of Washington · P01 · FY2023 · CA
Role of HSP70 in Pancreatic Diseases
$423,276Sundaram Ramakrishnan · University Of Miami School Of Medicine · R01 · FY2020 · CA
Metabolic interactions between tumor cells and the immunce system in GBM A potential Achilles heel of GBM for novel therapeutics
$423,255Loic Pierre Deleyrolle · University Of Florida · R01 · FY2022 · NS
Nanodelivery to enhance the imaging and therapy of breast cancer
$423,188Jan E Schnitzer · Proteogenomics Research Instit/Sys/ Med · R01 · FY2016 · CA
Nanodelivery to enhance the imaging and therapy of breast cancer
$423,188Jan E Schnitzer · Proteogenomics Research Instit/Sys/ Med · R01 · FY2017 · CA
Nanodelivery to enhance the imaging and therapy of breast cancer
$423,188Jan E Schnitzer · Proteogenomics Research Instit/Sys/ Med · R01 · FY2015 · CA